

FDA introduces new standardized inspection protocols for sterile drug manufacturers to modernize and strengthen oversight
FTC takes on deceptive stem cell therapy claims for blindness cure and autism treatment

FDA publishes internal policy on prioritizing surveillance inspections for drug manufacturing sites
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
The Crackdown Continues: FDA Takes Action Against Company And Its Autologous Stem Cell Product, Alleging Significant Safety Concerns
FDA Issues New Guidance Documents on Regenerative Medicine but Delays Enforcement
FDA to Rely on Drug Inspections Performed by Certain European Regulatory Authorities Beginning November 1, 2017
Blogs
Firm/Org